BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 25857358)

  • 1. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
    González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
    J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain.
    Kajitani N; Okada-Tsuchioka M; Kano K; Omori W; Boku S; Aoki J; Takebayashi M
    Biochem Biophys Res Commun; 2020 Oct; 531(2):89-95. PubMed ID: 32718668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid and its receptor LPA
    Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
    Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex.
    García-Díaz B; Riquelme R; Varela-Nieto I; Jiménez AJ; de Diego I; Gómez-Conde AI; Matas-Rico E; Aguirre JÁ; Chun J; Pedraza C; Santín LJ; Fernández O; Rodríguez de Fonseca F; Estivill-Torrús G
    Brain Struct Funct; 2015 Nov; 220(6):3701-20. PubMed ID: 25226845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
    Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R
    J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
    Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
    Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    González de San Román E; Llorente-Ovejero A; Martínez-Gardeazabal J; Moreno-Rodríguez M; Giménez-Llort L; Manuel I; Rodríguez-Puertas R
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPA
    Suckau O; Gross I; Schrötter S; Yang F; Luo J; Wree A; Chun J; Baska D; Baumgart J; Kano K; Aoki J; Bräuer AU
    Dev Dyn; 2019 May; 248(5):375-395. PubMed ID: 30847983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB
    González de San Román E; Manuel I; Ledent C; Chun J; Rodríguez de Fonseca F; Estivill-Torrús G; Santín LJ; Rodríguez Puertas R
    Front Mol Neurosci; 2019; 12():223. PubMed ID: 31607860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of lysophosphatidic acid receptor 1 mutants identified in rat cancer tissues.
    Ishii S; Tsujiuchi T; Fukushima N
    Biochem Biophys Res Commun; 2017 May; 486(3):767-773. PubMed ID: 28342860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
    Taleb SJ; Wei J; Mialki RK; Dong S; Li Y; Zhao J; Zhao Y
    J Cell Biochem; 2021 Aug; 122(8):827-834. PubMed ID: 33847006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.
    Gennero I; Laurencin-Dalicieux S; Conte-Auriol F; Briand-Mésange F; Laurencin D; Rue J; Beton N; Malet N; Mus M; Tokumura A; Bourin P; Vico L; Brunel G; Oreffo RO; Chun J; Salles JP
    Bone; 2011 Sep; 49(3):395-403. PubMed ID: 21569876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes.
    Hurst-Kennedy J; Boyan BD; Schwartz Z
    Biochim Biophys Acta; 2009 May; 1793(5):836-46. PubMed ID: 19233232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the LPA
    Tabbai S; Moreno-Fernández RD; Zambrana-Infantes E; Nieto-Quero A; Chun J; García-Fernández M; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Oliveira TG; Pérez-Martín M; Pedraza C
    Front Mol Neurosci; 2019; 12():146. PubMed ID: 31244601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.
    Uchida H; Nagai J; Ueda H
    Mol Pain; 2014 Nov; 10():71. PubMed ID: 25411045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of LPA1 signaling results in defective cortical development.
    Estivill-Torrús G; Llebrez-Zayas P; Matas-Rico E; Santín L; Pedraza C; De Diego I; Del Arco I; Fernández-Llebrez P; Chun J; De Fonseca FR
    Cereb Cortex; 2008 Apr; 18(4):938-50. PubMed ID: 17656621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.
    Hopkins MM; Liu Z; Meier KE
    J Pharmacol Exp Ther; 2016 Oct; 359(1):124-33. PubMed ID: 27474750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.